Structural bone allograft fractures in oncological procedures

International Orthopaedics
Javier Garcia-CoiradasLuis Lopez-Duran

Abstract

We report our experience analysing the risk of fracture amongst allografts in limb-preserving surgery for bone tumours. We retrospectively reviewed our experience with bone allograft and its major complications when used for limb -preserving operations for bone tumours. Forty-one structural allografts were performed in 39 patients between 1992 and 2012. Minimum follow-up was 20 months. Massive allografts have a high complication rate. Excluding infection and nonunion, five acute fractures were found. All fractures occurred after the graft-host junction was united. Local factors-such as graft preservation, weight bearing, fixation to the host or systemic factors such as adjuvant treatments (chemotherapy or radiotherapy)-influence fracture rate. In our study, four patients achieved consolidation with internal fixation and autologous iliac-crest graft, whilst only one required graft exchange. There is no general consensus as to when to treat fractures using open reduction and internal fixation or by exchanging the allograft. Higher fracture rate in relation to systemic treatment was found. Massive structural allograft reconstruction still has a place in limb-preserving surgery, with an acceptable fracture rate and a durable solution.

References

Jun 3, 1976·The New England Journal of Medicine·H J MankinF Jaffer
May 1, 1994·The Journal of Bone and Joint Surgery. American Volume·R A Vander Griend
Sep 1, 1995·Developmental and Comparative Immunology·C M PeddieV J Smith
Jan 1, 1997·The Journal of Bone and Joint Surgery. American Volume·E Ortiz-CruzH J Mankin
May 15, 1998·International Orthopaedics·M San-Julian, J Cañadell
Jun 15, 2000·Clinical Orthopaedics and Related Research·S A LietmanH J Mankin
Jun 3, 2005·Clinical Orthopaedics and Related Research·Enrico LucarelliDavide Donati
Nov 29, 2005·The Orthopedic Clinics of North America·D Luis MuscoloLuis A Aponte-Tinao
Oct 3, 2006·International Orthopaedics·Z MatejovskyI Kofranek
Dec 4, 2008·International Orthopaedics·P H J BullensH W B Schreuder
Oct 24, 2012·International Orthopaedics·Domenico CampanacciRodolfo Capanna
Apr 2, 2014·The Orthopedic Clinics of North America·Luis A Aponte-TinaoGerman L Farfalli
May 6, 2014·Clinical Orthopaedics and Related Research·Luis A Aponte-TinaoGermán L Farfalli

❮ Previous
Next ❯

Related Concepts

Related Feeds

Blood And Marrow Transplantation

The use of hematopoietic stem cell transplantation or blood and marrow transplantation (bmt) is on the increase worldwide. BMT is used to replace damaged or destroyed bone marrow with healthy bone marrow stem cells. Here is the latest research on bone and marrow transplantation.

Allogenic & Autologous Therapies

Allogenic therapies are generated in large batches from unrelated donor tissues such as bone marrow. In contrast, autologous therapies are manufactures as a single lot from the patient being treated. Here is the latest research on allogenic and autologous therapies.